ORA insider files Form 144 to sell 1,072 shares worth $91k
Ormat Technologies, Inc. (ORA) Form 144 filing discloses a planned sale of 1,072 common shares through Morgan Stanley Smith Barney on 18 June 2025.
Rhea-AI Filing Summary
Ormat Technologies, Inc. (ORA) Form 144 filing discloses a planned sale of 1,072 common shares through Morgan Stanley Smith Barney on 18 June 2025. The shares have an aggregate market value of $91,120. This represents roughly 0.0018 % of Ormat’s 60.66 million shares outstanding, indicating a very small transaction relative to overall float.
The seller, David Granot (relationship to issuer not specified in the filing), previously acquired the shares as restricted stock on 2 November 2023 (311 shares) and 9 May 2024 (761 shares). The filing also lists sales by the same individual during the last three months: 838 shares sold on 14 May 2025 for $61,176 and 112 shares sold on 13 May 2025 for $8,270.
No financial performance data or operational updates are included; the document is limited to disclosure of the proposed insider transaction under SEC Rule 144. Given the modest size of the sale, it is unlikely to have a material impact on ORA’s share price, but investors may nevertheless track insider selling trends for sentiment signals.
Positive
- None.
Negative
- Repeated insider sales: 1,072 shares planned plus 950 shares sold in May 2025 could be viewed cautiously by some investors despite the small size.
Insights
TL;DR: Small Rule 144 sale; limited governance impact.
This Form 144 shows an insider planning to sell 1,072 Ormat shares worth about $91k—only 0.002 % of shares outstanding. The filing meets regulatory requirements and provides no indication of undisclosed adverse information (standard Rule 144 attestation). The transaction size is immaterial to capital structure and unlikely to influence market liquidity or control. Nonetheless, continued sales (950 shares earlier in May) may be monitored by governance-focused investors for patterns of insider disposition, even though no qualitative concerns arise from this filing alone.
TL;DR: Insider sale is minor; sentiment slightly negative.
From a trading perspective, the proposed divestiture equals roughly one day’s average trading volume for ORA and should not pressure the stock. There is no accompanying operational disclosure, so valuation drivers remain unchanged. However, insider selling—even in small blocks—can weigh modestly on sentiment when aggregated over time. Investors may compare this activity with peer insider transactions and Ormat’s historical patterns but, in isolation, the event is not a catalyst.
FAQ
What did Ormat Technologies (ORA) disclose in the latest Form 144?
Have there been recent sales by the same individual?
Does the Form 144 include any financial or operational updates on ORA?
AI-generated analysis. How Rhea-AI works. Not financial advice.